Seagen
SGEN
#546
Rank
โ‚น3.876 T
Marketcap
โ‚น20,549
Share price
-0.07%
Change (1 day)
79.20%
Change (1 year)

Seagen (SGEN) - Cash on Hand

Cash on Hand as of September 2023 : โ‚น111.12 Billion

According to Seagen 's latest financial reports the company has โ‚น111.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Seagen - Cash on Hand chart (from 2001 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚น143.57 B-10.7%
2021-12-31โ‚น160.77 B-17.36%
2020-12-31โ‚น194.55 B214.19%
2019-12-31โ‚น61.92 B92.57%
2018-12-31โ‚น32.15 B21.89%
2017-12-31โ‚น26.38 B-37.28%
2016-12-31โ‚น42.06 B-11.19%
2015-12-31โ‚น47.36 B138.44%
2014-12-31โ‚น19.86 B-14.09%
2013-12-31โ‚น23.12 B15.93%
2012-12-31โ‚น19.94 B14.01%
2011-12-31โ‚น17.49 B38.53%
2010-12-31โ‚น12.62 B4.35%
2009-12-31โ‚น12.10 B164.52%
2008-12-31โ‚น4.57 B4.68%
2007-12-31โ‚น4.37 B19.48%
2006-12-31โ‚น3.65 B91.39%
2005-12-31โ‚น1.91 B18.83%
2004-12-31โ‚น1.60 B-13.48%
2003-12-31โ‚น1.85 B46.95%
2002-12-31โ‚น1.26 B-37.46%
2001-12-31โ‚น2.02 B78.12%
2000-12-31โ‚น1.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ImmunoGen
IMGN
โ‚น54.39 B-51.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น355.78 B 220.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น52.39 B-52.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚น5.04 B-95.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.346 T 1,111.33%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น399.26 B 259.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
โ‚น509.46 B 358.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.482 T 1,234.04%๐Ÿ‡บ๐Ÿ‡ธ USA